Earnings call: G1 Therapeutics reports growth and optimistic outlook By Investing.com

Published on 2 May 2024 on Investing.com

G1 Therapeutics (NASDAQ:GTHX) has reported promising financial results in their first-quarter...

Read the rest of the article

Start tracking your investments with Statfolio

Key Insights G1 Therapeutics will host its Annual General Meeting on 13th of JuneTotal pay for CE...

Simply Wall St. · via Yahoo Finance 19 Jun 2024

Shareholders of G1 Therapeutics, Inc. (NASDAQ:GTHX) will be pleased this week, given that the sto...

Simply Wall St. via Yahoo Finance 4 May 2024

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript May 1, 2024 G1 Therapeutics,...

Insider Monkey via Yahoo Finance 3 May 2024

G1 Therapeutics (NASDAQ:GTHX) has reported promising financial results in their first-quarter...

Investing.com 2 May 2024

Revenue: Reported $14.1 million from COSELA sales in Q1 2024, slightly below the estimated $15.26...

GuruFocus.com via Yahoo Finance 1 May 2024

We feel now is a pretty good time to analyse G1 Therapeutics, Inc.'s (NASDAQ:GTHX) business as it...

Simply Wall St. via Yahoo Finance 19 Apr 2024

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript February 28, 2024 G1 Therape...

Insider Monkey via Yahoo Finance 29 Feb 2024

Net Revenue Growth: G1 Therapeutics Inc (NASDAQ:GTHX) achieved a 48% increase in net revenue from...

GuruFocus.com via Yahoo Finance 28 Feb 2024

Key Insights The considerable ownership by individual investors in G1 Therapeutics indicates that...

Simply Wall St. via Yahoo Finance 17 Feb 2024

On January 2, 2024, Bailey John E. (Jack) Jr., the President and CEO of G1 Therapeutics Inc (NASD...

GuruFocus.com via Yahoo Finance 3 Jan 2024